Latest filing published 03 Jul 2014 for Oncternal Therapeutics, Inc., €33k.
Insider track record
No signal scores available.
James T. Dalton: trading record in brief
This profile gathers the share dealings of James T. Dalton in Oncternal Therapeutics, Inc. In total, 7 filings cover trades dated from 14 March 2007 to 6 June 2014.
Sales make up the whole of the open-market record (3 sales, €148k). The totals exclude 1 filing filed without an amount. Besides market trades, the filings include 2 share grants and 2 option exercises. Since January 2014: no purchases and 1 sale on the market.
Most recently, on 3 July 2014, the filings show a share grant worth €33k in Oncternal Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James T. Dalton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,117 shares@ US$1.66Common StockSEC:0001179110-14-011493:0
- 72,883 shares@ US$1.30Common StockSEC:0001179110-14-010033:0
- 100,000 shares0Common StockSEC:0001179110-13-014969:0
- 20,000 shares@ US$2.65Common StockSEC:0001209191-13-003652:0
- 20,000 shares@ US$5.20Common StockSEC:0001209191-13-003652:1
- 17,000 shares@ US$13.07Common StockSEC:0001209191-07-017967:0
- 17,000 sharesCommon StockSEC:0001209191-07-017967:1
7 of 7 declarations
